0DTK Stock Chart & Stats
€62.40
€1.50(3.01%)
At close: 4:00 PM EST
€62.40
€1.50(3.01%)
Day’s Range― - ―
52-Week Range€54.40 - €74.40
Previous CloseN/A
Volume0.00
Average Volume (3M)4.00
Market Cap
€773.53M
Enterprise Value€2.09B
Total Cash (Recent Filing)€726.99M
Total Debt (Recent Filing)€1.70B
Price to Earnings (P/E)9.8
Beta0.03
Next Earnings
Mar 11, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.51%
Share Statistics
EPS (TTM)5.55
Shares Outstanding14,032,930
10 Day Avg. Volume5
30 Day Avg. Volume4
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.52
Price to Sales (P/S)0.13
P/FCF Ratio14.73
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)10.9
Revenue Forecast (FY)€7.72B
Bulls Say, Bears Say
Bulls Say
Manageable LeverageLeverage remains moderate for a packaged-foods company, with debt-to-equity broadly stable and equity relatively resilient. This provides Savencia with more financial flexibility than a highly indebted peer, although modest returns mean the balance-sheet cushion still depends on protecting earnings.
Diversified Revenue ChannelsThe combination of branded consumer products, specialty and foodservice sales, and recurring B2B dairy demand gives Savencia several routes to market. This channel breadth can support customer reach and revenue resilience because performance is not tied to one selling format or end market.
Established Operating ScaleSavencia has demonstrated substantial operating scale and maintained a solid gross-margin range despite the recent slowdown. That underlying product and distribution base can support continued investment, brand presence, and operational recovery if management restores revenue growth and profitability.
Bears Say
Recent Revenue ContractionThe 2025 sales decline interrupts Savencia’s prior multi-year revenue progression and signals weaker recent demand or mix. Sustained contraction would reduce operating leverage, constrain investment capacity, and make it harder for the company to absorb fixed costs across its dairy portfolio.
Thin And Weakening ProfitabilityA very thin net margin leaves limited protection against cost pressure or further revenue weakness. The simultaneous compression in EBIT and EBITDA margins suggests reduced operating leverage, making earnings recovery dependent on improving pricing, mix, or cost control rather than growth alone.
Weak Cash ConversionPositive but inconsistent cash generation reduces the quality and flexibility of reported earnings. With free cash flow covering only a small share of net income, Savencia has less internally generated capacity for debt reduction, dividends, reinvestment, or absorbing additional operating volatility.
Savencia News
0DTK FAQ
What was Savencia SA’s price range in the past 12 months?
Savencia SA lowest share price was €54.40 and its highest was €74.40 in the past 12 months.
What is Savencia SA’s market cap?
Savencia SA’s market cap is €773.53M.
When is Savencia SA’s upcoming earnings report date?
Savencia SA’s upcoming earnings report date is Mar 11, 2027 which is in 139 days.
How were Savencia SA’s earnings last quarter?
Savencia SA released its earnings results on Sep 10, 2026. The company reported €2.913 earnings per share for the quarter.
Is Savencia SA overvalued?
According to Wall Street analysts Savencia SA’s price is currently Overvalued.
Does Savencia SA pay dividends?
Savencia SA pays a Annually dividend of €1.4 which represents an annual dividend yield of 2.51%. See more information on Savencia SA dividends here
What is Savencia SA’s EPS estimate?
Savencia SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Savencia SA have?
Savencia SA has 14,032,930 shares outstanding.
What happened to Savencia SA’s price movement after its last earnings report?
Savencia SA reported an EPS of €2.913 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Savencia SA?
Currently, no hedge funds are holding shares in GB:0DTK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Savencia SA
Savencia SA is a French-headquartered enterprise, established in 1956, specializing in the production of dairy items for both domestic and international markets. The company's product portfolio encompasses a diverse range of cheeses, along with butters and creams supplied to consumer retail outlets and professional catering services. Additionally, it furnishes dairy ingredients for the food, nutrition, and healthcare sectors. Known as Bongrain SA until its rebranding in April 2015, the firm now operates under the name Savencia SA and is based in Viroflay, France.
Technical Analysis
Bonduelle
―
DANONE SA
―
Fleury Michon
―
Societe LDC Societe Anonyme
―
Saint Jean Groupe SA
―



